Protocol Ledger

NCT04661358 · Phase III · ACTIVE NOT RECRUITING

Fenofibrate for Prevention of DR Worsening

Interventional Phase III clinical trial protocol NCT04661358 sponsored by Jaeb Center for Health Research in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-03-05 Enrollment: 563 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04661358
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)563 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04661358
Protocol FieldVerified Registry Value
NCT IdentifierNCT04661358
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment563 participants (ACTUAL)
Registered Start Date2021-03-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI